FilingReader Intelligence

Takeda reports revenue decline but profit surge in Q1

July 30, 2025 at 12:05 PM UTCBy FilingReader AI

Takeda Pharmaceutical reported Q1 revenue of 1,106.7bn yen, down 8.4% year-over-year, hit by unfavorable foreign exchange rates and declining neuroscience sales.

Operating profit rose 11% to 184.6bn yen, while net profit surged 30.4% to 124.2bn yen. The revenue decline was partly driven by generic erosion of VYVANSE in the U.S.

Full-year guidance remains unchanged across core revenue, operating profit and earnings per share.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Takeda Pharmaceutical Company Limited publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →